GrippeFranceV1, Main, Exploration, bibRecord, 000761

Antibody response to anti-A/New Jersey/76 vaccines.

Identifieur interne : 000761 ( Main/Exploration ); précédent : 000760; suivant : 000762

Antibody response to anti-A/New Jersey/76 vaccines.

Auteurs : C. Hannoun ; M. Barme ; C. Sérié ; H. Beck ; J. Aquino ; M. Thibon

Source :

Developments in biological standardization [ 0301-5149 ]

RBID : pubmed:604105

Descripteurs français

KwdFr :
- Adulte (MeSH), Adulte d'âge moyen (MeSH), Anticorps antiviraux (MeSH), Facteurs âges (MeSH), France (MeSH), Humains (MeSH), Hémagglutinines virales (MeSH), Production d'anticorps (MeSH), Rappel de vaccin (MeSH), Sujet âgé (MeSH), Vaccins antigrippaux (MeSH), Virus de la grippe A (immunologie).
MESH :
- immunologie : Virus de la grippe A.
- Adulte, Adulte d'âge moyen, Anticorps antiviraux, Facteurs âges, France, Humains, Hémagglutinines virales, Production d'anticorps, Rappel de vaccin, Sujet âgé, Vaccins antigrippaux.
Wicri :
- geographic : France.

English descriptors

KwdEn :
- Adult (MeSH), Age Factors (MeSH), Aged (MeSH), Antibodies, Viral (MeSH), Antibody Formation (MeSH), France (MeSH), Hemagglutinins, Viral (MeSH), Humans (MeSH), Immunization, Secondary (MeSH), Influenza A virus (immunology), Influenza Vaccines (MeSH), Middle Aged (MeSH).
MESH :
- chemical : Antibodies, Viral, Hemagglutinins, Viral, Influenza Vaccines.
- geographic : France.
- immunology : Influenza A virus.
- Adult, Age Factors, Aged, Antibody Formation, Humans, Immunization, Secondary, Middle Aged.

Abstract

Experimental inactivated influenza vaccines prepared with strain X 53, derived from A/New Jersey/76 virus were injected to several groups of subjects. Different compositions of vaccine were used and the subjects were selected from different age groups. Antibody responses were measured 15 days after vaccination; it was then possible to evaluate the conversion rates, the percentages of subjects showing a protective level of antibodies and the average level of antibodies. The results show that a very small dose of antigen, probably acting as a booster, gives very good results in the older age group. On the other hand, young adults (below 23) react to a much lower degree to the vaccine. The results are discussed in relation to the age distribution of preexisting antibodies in the experimental groups and in the general population in France.

PubMed: 604105

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000761
to stream Main, to step Curation: 000761

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Antibody response to anti-A/New Jersey/76 vaccines.</title>
<author><name sortKey="Hannoun, C" sort="Hannoun, C" uniqKey="Hannoun C" first="C" last="Hannoun">C. Hannoun</name>
</author>
<author><name sortKey="Barme, M" sort="Barme, M" uniqKey="Barme M" first="M" last="Barme">M. Barme</name>
</author>
<author><name sortKey="Serie, C" sort="Serie, C" uniqKey="Serie C" first="C" last="Sérié">C. Sérié</name>
</author>
<author><name sortKey="Beck, H" sort="Beck, H" uniqKey="Beck H" first="H" last="Beck">H. Beck</name>
</author>
<author><name sortKey="Aquino, J" sort="Aquino, J" uniqKey="Aquino J" first="J" last="Aquino">J. Aquino</name>
</author>
<author><name sortKey="Thibon, M" sort="Thibon, M" uniqKey="Thibon M" first="M" last="Thibon">M. Thibon</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1977">1977 Jun 1-3</date>
<idno type="RBID">pubmed:604105</idno>
<idno type="pmid">604105</idno>
<idno type="wicri:Area/Main/Corpus">000761</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000761</idno>
<idno type="wicri:Area/Main/Curation">000761</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000761</idno>
<idno type="wicri:Area/Main/Exploration">000761</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Antibody response to anti-A/New Jersey/76 vaccines.</title>
<author><name sortKey="Hannoun, C" sort="Hannoun, C" uniqKey="Hannoun C" first="C" last="Hannoun">C. Hannoun</name>
</author>
<author><name sortKey="Barme, M" sort="Barme, M" uniqKey="Barme M" first="M" last="Barme">M. Barme</name>
</author>
<author><name sortKey="Serie, C" sort="Serie, C" uniqKey="Serie C" first="C" last="Sérié">C. Sérié</name>
</author>
<author><name sortKey="Beck, H" sort="Beck, H" uniqKey="Beck H" first="H" last="Beck">H. Beck</name>
</author>
<author><name sortKey="Aquino, J" sort="Aquino, J" uniqKey="Aquino J" first="J" last="Aquino">J. Aquino</name>
</author>
<author><name sortKey="Thibon, M" sort="Thibon, M" uniqKey="Thibon M" first="M" last="Thibon">M. Thibon</name>
</author>
</analytic>
<series><title level="j">Developments in biological standardization</title>
<idno type="ISSN">0301-5149</idno>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term>
<term>Age Factors (MeSH)</term>
<term>Aged (MeSH)</term>
<term>Antibodies, Viral (MeSH)</term>
<term>Antibody Formation (MeSH)</term>
<term>France (MeSH)</term>
<term>Hemagglutinins, Viral (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Immunization, Secondary (MeSH)</term>
<term>Influenza A virus (immunology)</term>
<term>Influenza Vaccines (MeSH)</term>
<term>Middle Aged (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Anticorps antiviraux (MeSH)</term>
<term>Facteurs âges (MeSH)</term>
<term>France (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Hémagglutinines virales (MeSH)</term>
<term>Production d'anticorps (MeSH)</term>
<term>Rappel de vaccin (MeSH)</term>
<term>Sujet âgé (MeSH)</term>
<term>Vaccins antigrippaux (MeSH)</term>
<term>Virus de la grippe A (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Antibodies, Viral</term>
<term>Hemagglutinins, Viral</term>
<term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>France</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A virus</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Age Factors</term>
<term>Aged</term>
<term>Antibody Formation</term>
<term>Humans</term>
<term>Immunization, Secondary</term>
<term>Middle Aged</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Anticorps antiviraux</term>
<term>Facteurs âges</term>
<term>France</term>
<term>Humains</term>
<term>Hémagglutinines virales</term>
<term>Production d'anticorps</term>
<term>Rappel de vaccin</term>
<term>Sujet âgé</term>
<term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>France</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Experimental inactivated influenza vaccines prepared with strain X 53, derived from A/New Jersey/76 virus were injected to several groups of subjects. Different compositions of vaccine were used and the subjects were selected from different age groups. Antibody responses were measured 15 days after vaccination; it was then possible to evaluate the conversion rates, the percentages of subjects showing a protective level of antibodies and the average level of antibodies. The results show that a very small dose of antigen, probably acting as a booster, gives very good results in the older age group. On the other hand, young adults (below 23) react to a much lower degree to the vaccine. The results are discussed in relation to the age distribution of preexisting antibodies in the experimental groups and in the general population in France.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">604105</PMID>
<DateCompleted><Year>1978</Year>
<Month>04</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised><Year>2005</Year>
<Month>11</Month>
<Day>22</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0301-5149</ISSN>
<JournalIssue CitedMedium="Print"><Volume>39</Volume>
<PubDate><MedlineDate>1977 Jun 1-3</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Developments in biological standardization</Title>
<ISOAbbreviation>Dev. Biol. Stand.</ISOAbbreviation>
</Journal>
<ArticleTitle>Antibody response to anti-A/New Jersey/76 vaccines.</ArticleTitle>
<Pagination><MedlinePgn>249-52</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Experimental inactivated influenza vaccines prepared with strain X 53, derived from A/New Jersey/76 virus were injected to several groups of subjects. Different compositions of vaccine were used and the subjects were selected from different age groups. Antibody responses were measured 15 days after vaccination; it was then possible to evaluate the conversion rates, the percentages of subjects showing a protective level of antibodies and the average level of antibodies. The results show that a very small dose of antigen, probably acting as a booster, gives very good results in the older age group. On the other hand, young adults (below 23) react to a much lower degree to the vaccine. The results are discussed in relation to the age distribution of preexisting antibodies in the experimental groups and in the general population in France.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hannoun</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y"><LastName>Barme</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Sérié</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y"><LastName>Beck</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y"><LastName>Aquino</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Thibon</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>Switzerland</Country>
<MedlineTA>Dev Biol Stand</MedlineTA>
<NlmUniqueID>0427140</NlmUniqueID>
<ISSNLinking>0301-5149</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D006389">Hemagglutinins, Viral</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000917" MajorTopicYN="N">Antibody Formation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006389" MajorTopicYN="N">Hemagglutinins, Viral</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007117" MajorTopicYN="N">Immunization, Secondary</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009980" MajorTopicYN="N">Influenza A virus</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007252" MajorTopicYN="Y">Influenza Vaccines</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1977</Year>
<Month>6</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>1977</Year>
<Month>6</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>1977</Year>
<Month>6</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">604105</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list></list>
<tree><noCountry><name sortKey="Aquino, J" sort="Aquino, J" uniqKey="Aquino J" first="J" last="Aquino">J. Aquino</name>
<name sortKey="Barme, M" sort="Barme, M" uniqKey="Barme M" first="M" last="Barme">M. Barme</name>
<name sortKey="Beck, H" sort="Beck, H" uniqKey="Beck H" first="H" last="Beck">H. Beck</name>
<name sortKey="Hannoun, C" sort="Hannoun, C" uniqKey="Hannoun C" first="C" last="Hannoun">C. Hannoun</name>
<name sortKey="Serie, C" sort="Serie, C" uniqKey="Serie C" first="C" last="Sérié">C. Sérié</name>
<name sortKey="Thibon, M" sort="Thibon, M" uniqKey="Thibon M" first="M" last="Thibon">M. Thibon</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeFranceV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000761 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000761 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GrippeFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:604105
   |texte=   Antibody response to anti-A/New Jersey/76 vaccines.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:604105" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeFranceV1

This area was generated with Dilib version V0.6.35.
Data generation: Sun Aug 9 07:31:43 2020. Site generation: Thu Mar 25 22:05:26 2021

	Serveur d'exploration sur la grippe en France
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur la grippe en France

Antibody response to anti-A/New Jersey/76 vaccines.

Antibody response to anti-A/New Jersey/76 vaccines.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki